Based on Columbia research, an experimental drug for a rare type of ALS is being tested in a phase 3 clinical trial after a new study found that the drug lowered levels of a toxic protein.
Just a single type of neuron controls the complex patterns of walking, a surprising finding that may lead to new therapeutic approaches for people with spinal cord injuries.
A new study at Columbia University Irving Medical Center seeks volunteers to determine if intermittent fasting leads to long-term weight loss and health benefits.
New Columbia research suggests that targeting neighboring bone cells may be a better strategy than targeting malignant stem cells to treat acute myeloid leukemia.
Dr. Maura Boldrini, a neuroscientist at Columbia University, says new research could have far-reaching implications for other mental illnesses beyond COVID.
